Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration
- 1 September 2007
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 122 (1) , 102-110
- https://doi.org/10.1016/j.jconrel.2007.06.010
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health, Labour and Welfare
- Japan Health Sciences Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 41 references indexed in Scilit:
- Adenovirus Type 5 Interactions with Human Blood Cells May Compromise Systemic DeliveryMolecular Therapy, 2006
- Addition of low-dose tumor necrosis factor-?? to systemic treatment with STEALTH liposomal doxorubicin (Doxil) improved anti-tumor activity in osteosarcoma-bearing ratsAnti-Cancer Drugs, 2005
- Transcriptional targeting of RGD fiber-mutant adenovirus vectors can improve the safety of suicide gene therapy for murine melanomaCancer Gene Therapy, 2005
- Macromolecular TherapeuticsClinical Pharmacokinetics, 2003
- Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinaseCancer Gene Therapy, 2002
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- In Vitro Remodeling of Tumor Vascular Endothelial Cells Using Conditioned Medium from Various Tumor Cells and Their Sensitivity to TNF-αBiochemical and Biophysical Research Communications, 2000
- Efficient Construction of a Recombinant Adenovirus Vector by an ImprovedIn VitroLigation MethodHuman Gene Therapy, 1998
- Efficient Identification of Recombinant Adenoviruses by Direct Plaque ScreeningDNA and Cell Biology, 1998
- In vivoAnti-tumor Efficacy of Polyethylene Glycol-modified Tumor Necrosis Factor-α against Tumor Necrosis Factor-resistant TumorsJapanese Journal of Cancer Research, 1996